Azitra, Inc. (AZTR)
NYSEAMERICAN: AZTR · Real-Time Price · USD
0.1516
-0.0075 (-4.71%)
Aug 12, 2025, 11:39 AM - Market open
Chuy's Holdings Employees
Azitra had 12 employees as of December 31, 2024. The number of employees increased by 2 or 20.00% compared to the previous year.
Employees
12
Change (1Y)
2
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-$779,997
Market Cap
2.61M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12 | 2 | 20.00% |
| Dec 31, 2023 | 10 | 0 | - |
| Dec 31, 2022 | 10 | 0 | - |
| Dec 31, 2021 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AZTR News
- 18 hours ago - Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates - PRNewsWire
- 19 hours ago - Azitra, Inc. Announces Reverse Stock Split - PRNewsWire
- 2 months ago - Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome - PRNewsWire
- 2 months ago - Azitra, Inc. Announces Presentation at the 2025 BIO International Convention - PRNewsWire
- 2 months ago - Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash - PRNewsWire
- 3 months ago - Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash - PRNewsWire
- 3 months ago - Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates - PRNewsWire
- 3 months ago - Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025 - PRNewsWire